- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 18.64M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 18.64M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.64M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $2.26M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $1.99M |
| Capex | Q1 2026 · Mar 31, 2026 | $599K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.77M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$14.48M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $36.74M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $36.88M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $409.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $338.95M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $361.02M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $340.17M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $299.8M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $97.41M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.23B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.89 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.23 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $3.89 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.23 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $723K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.1M |
| Net Income | Q1 2026 · Mar 31, 2026 | $72.53M |
| Net Income | Q1 2026 · Mar 31, 2025 | $22.84M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.33M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $1.72M |
| Revenue | Q1 2026 · Mar 31, 2026 | $18.29M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $19.02M |